• Company
• Viatrice Korea appoints Bill Schuster as new CEO
• by Jung, Sae-Im Mar 30, 2023 05:42am

• Policy
• New Pompe disease drug Nexviazyme is approved in Korea
• by Lee, Hye-Kyung Mar 30, 2023 05:41am

• Opinion
• [Reporter’s View] Accepting drugs used by very few patients
• by Eo, Yun-Ho Mar 30, 2023 05:41am

• Policy
• Obizur will be evaluated for reimbursement upon approval
• by Lee, Tak-Sun Mar 30, 2023 05:41am

• Policy
• Govt seeks to improve the drug price reduction system
• by Lee, Tak-Sun Mar 29, 2023 06:02am

• Company
• JW Pharma registers the first overseas patent for JW0061
• by Mar 29, 2023 06:02am

• Company
• Bridge Biotherapeutics applies to FDA for the phase 1/2 plan
• by Mar 29, 2023 06:02am

• Company
• TB treatment Dovprela lands in general hospitals in Korea
• by Eo, Yun-Ho Mar 29, 2023 06:02am

• Policy
• 87.5% of anticancer/rare drugs, evaluated as drugs w/o PE
• by Lee, Tak-Sun Mar 29, 2023 06:01am

• Policy
• Erleada is listed
• by Lee, Tak-Sun Mar 28, 2023 05:56am